简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
Research and Development Collaboration
INSILICO(03696.HK) Enters AI-Powered R&D Collaboration with SK Biopharmaceuticals, Total Potential Deal Value Exceeds USD2.5 Billion
Tags:
Insilico
03696.HK
Research and Development Collaboration
2026-06-22
Featured News
Finance
Hengrui Medicine (01276.HK): Marketing Authorization Application for Relugolix Tablets Accepted by EMA
Finance
Regina Miracle International (02199.HK): Positive Profit Alert, Annual Net Profit Expected to Rise by No Less Than 45%
Finance
Dingli Capital (00356.HK): Completes Placing of Approximately 286 Million New Shares, Raising Around HK$13.99 Million
Finance
Shandong Xinhua Pharmaceutical Company Limited (00719.HK): LXH-2103 Injection Approved for Clinical Trials
Finance
Asiatic Group Holdings Proposes to Sell 49% Stake in Cambodian Joint Venture for US$3.1 Million
Finance
F J Benjamin Holdings Proposes Placing 42 Million New Ordinary Shares to Raise Approximately S$302,400
ETF
Chinaamc Hang Seng Tech Index Etf(03088.HK) Falls 0.51% Intraday at HK$5.815
ETF
Tracker Fund Of Hong Kong(02800.HK) Drops 0.41% Intraday, Turnover Reaches HK$14.452 Billion
Research
HK.AI CAPITAL (01140.HK) Forecasts Net Profit to Surge Over 90x; Institutions Expect Hong Kong Stocks' Valuation Recovery to Continue
ETF
E Fund (Hk) Ftse Ai Select Index Etf(03489.HK) Falls 0.49% Intraday, Turnover Hits HK$55.983 Million
Scan QR Code
Download App